# BeneFIX Drug Use Results Survey [All-Case Surveillance]

> **NCT01154231** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 314 (actual)

## Conditions studied

- Hemophilia B

## Interventions

- **DRUG:** Nonacog Alfa (Genetical Recombination)

## Key facts

- **NCT ID:** NCT01154231
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-29
- **Primary completion:** 2014-08-29
- **Final completion:** 2017-02-27
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01154231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01154231, "BeneFIX Drug Use Results Survey [All-Case Surveillance]". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01154231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*